Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MARTIN, LISA

NPI: 1245204122 · NAPERVILLE, IL 60563 · Pediatrics Physician · NPI assigned 02/15/2006

$920K
Total Medicaid Paid
20,549
Total Claims
16,643
Beneficiaries
41
Codes Billed
2018-01
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,510 $63K
2019 2,288 $102K
2020 1,875 $69K
2021 2,344 $94K
2022 4,068 $184K
2023 3,709 $173K
2024 4,755 $237K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4,871 4,063 $237K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 2,635 2,251 $206K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 695 586 $98K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,157 879 $88K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 949 693 $65K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 544 475 $41K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 309 257 $26K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 722 668 $17K
96110 Developmental screening, with scoring and documentation, per standardized instrument 1,015 823 $16K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 406 247 $14K
96127 670 570 $12K
96160 811 585 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 547 349 $12K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 27 27 $9K
92551 551 446 $8K
90698 509 363 $7K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 164 113 $7K
90686 588 503 $6K
D1206 Topical application of fluoride varnish 228 179 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 138 120 $6K
90670 279 215 $4K
90671 180 114 $3K
90651 123 87 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 146 129 $2K
83655 188 152 $2K
99173 271 218 $2K
85018 785 648 $2K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 104 86 $2K
90674 73 67 $1K
90680 70 53 $974.22
99174 118 100 $879.10
90661 51 45 $835.50
83718 105 86 $797.42
36416 164 133 $668.30
90734 12 12 $584.60
94760 154 135 $520.68
82465 100 86 $416.06
90744 34 30 $387.54
90633 29 24 $331.95
90700 14 13 $175.84
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 13 13 $167.44